Lucas Dada

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Topics

Escherichia Coli

Molecular Docking

Protein Protein

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Organic & biomolecular chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Seiya Kitamura, Ting-Hui Lin, Chang-Chun David Lee, Akihiro Takamura, Rameshwar U Kadam, Ding Zhang, Xueyong Zhu, Lucas Dada, Emiko Nagai, Wenli Yu, Yao Yao, K Barry Sharpless, Ian A Wilson, Dennis W Wolan
Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry. Proceedings of the National Academy of Sciences of the United States of America 121 (22) (2024)
Seiya Kitamura, Ting-Hui Lin, Chang-Chun David Lee, Akihiro Takamura, Rameshwar U Kadam, Ding Zhang, Xueyong Zhu, Lucas Dada, Emiko Nagai, Wenli Yu, Yao Yao, K Barry Sharpless, Ian A Wilson, Dennis W Wolan
Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry. Proceedings of the National Academy of Sciences of the United States of America 121 (22) (2024)
Seiya Kitamura, Ting-Hui Lin, Chang-Chun David Lee, Akihiro Takamura, Rameshwar U Kadam, Ding Zhang, Xueyong Zhu, Lucas Dada, Emiko Nagai, Wenli Yu, Yao Yao, K Barry Sharpless, Ian A Wilson, Dennis W Wolan
Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry. Proceedings of the National Academy of Sciences of the United States of America 121 (22) (2024)
Seiya Kitamura, Ting-Hui Lin, Chang-Chun David Lee, Akihiro Takamura, Rameshwar U Kadam, Ding Zhang, Xueyong Zhu, Lucas Dada, Emiko Nagai, Wenli Yu, Yao Yao, K Barry Sharpless, Ian A Wilson, Dennis W Wolan
Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry. Proceedings of the National Academy of Sciences of the United States of America 121 (22) (2024)
Seiya Kitamura, Ting-Hui Lin, Chang-Chun David Lee, Akihiro Takamura, Rameshwar U Kadam, Ding Zhang, Xueyong Zhu, Lucas Dada, Emiko Nagai, Wenli Yu, Yao Yao, K Barry Sharpless, Ian A Wilson, Dennis W Wolan
Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry. Proceedings of the National Academy of Sciences of the United States of America 121 (22) (2024)
Lucas Dada, Juan Pablo Colomer, Verónica E Manzano, Oscar Varela
Synthesis of thiodisaccharides related to 4-thiolactose. Specific structural modifications increase the inhibitory activity against E. coli β-galactosidase. Organic & biomolecular chemistry (2023)
Lucas Dada, Juan Pablo Colomer, Verónica E Manzano, Oscar Varela
Synthesis of thiodisaccharides related to 4-thiolactose. Specific structural modifications increase the inhibitory activity against E. coli β-galactosidase. Organic & biomolecular chemistry 21 (10) (2023)
Lucas Dada, Juan Pablo Colomer, Verónica E Manzano, Oscar Varela
Synthesis of thiodisaccharides related to 4-thiolactose. Specific structural modifications increase the inhibitory activity against E. coli β-galactosidase. Organic & biomolecular chemistry 21 (10) (2023)
Lucas Dada, Juan Pablo Colomer, Verónica E Manzano, Oscar Varela
Synthesis of thiodisaccharides related to 4-thiolactose. Specific structural modifications increase the inhibitory activity against E. coli β-galactosidase. Organic & biomolecular chemistry 21 (10) (2023)